Aldeyra Therapeutics, Inc. (ALDX) is a publicly traded Healthcare sector company. As of August 7, 2026, ALDX trades at $1.56 with a market cap of $96.51M and a P/E ratio of -2.83. ALDX moved -1.26% today. Year to date, ALDX is -65.95%; over the trailing twelve months it is -69.54%. Its 52-week range spans $1.07 to $7.20. Analyst consensus is neutral with an average price target of $2.00. Rallies surfaces ALDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for ALDX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $1.56 |
| Market Cap | $96.51M |
| P/E Ratio | -2.83 |
| EPS | $-0.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.20 |
| 52-Week Low | $1.07 |
| Volume | 191.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-33.85M |
| Gross Margin | 0.00% |
1 analysts cover ALDX: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.00.